SBIR/STTR Research Award
ASSAY SYSTEM FOR CLONED GI-COUPLED RECEPTORS
Award amount
$400,293Program and phase
SBIR · Phase IIAward year
1991Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- Synaptic Pharmaceutical Corp.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
MOLECULAR CLONING AND HETEROLOGOUS EXPRESSION OF NEUROTRANSMITTER RECEPTOR GENES PROVIDE A MEANS TO STUDY THESE SITES OF DRUG ACTION FREE FROM THE COMPLEXITIES OF INTACT NEURAL TISSUE. THESE HETEROLOGOUS EXPRESSION SYSTEMSCAN THEN BE USED AS ASSAY SYSTEMS IN THE DEVELOPMENT OF NEW THERAPEUTIC AGENTS. RECENTLY, A GENOMIC CLONE FOR THE SEROTONIN 5-HT1A RECEPTOR WAS REPORTED. THIS RECEPTOR HAS BEEN ASSOCIATED WITH SEVERAL CENTRAL AND PERIPHERAL NERVOUS SYSTEM ACTIONS, INCLUDING ANXIETY, THERMOREGULATION,AND HYPOTENSION. ALTHOUGH THE TRANSFECTED 5-HT1A RECEPTOR HAS BEEN STUDIED BY LIGAND-BINDING APPROACHES, FUNCTIONAL EXPRESSION OF THIS CLONED GENE HAS NOT BEEN DEMONSTRATED. ON A SECOND-MESSENGER LEVEL, THE 5-HT1A RECEPTOR HAS BEEN ASSOCIATED WITH BOTH ACTIVATION AND INHIBITION OF ADENYLATE CYCLASE ACTIVITY. THE GOAL OF THIS RESEARCH IS TO TRANSFECT THE 5-HT1A RECEPTOR GENE INTO SUITABLE MAMMALIAN CELL HOSTS FOR THE STUDY OF ITS FUNCTIONAL COUPLING TO THE ADENYLATE CYCLASE SECOND-MESSENGER SYSTEM. THIS HETEROLOGOUS EXPRESSION SYSTEM CAN THEN BE USED AS A FUNCTIONAL ASSAY FOR THE DEVELOPMENT OF NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF ANXIETY OR OTHER DISEASE STATES INVOLVING 5-HT1A RECEPTORS. IN ADDITION, THIS EXPRESSION SYSTEM FOR RECEPTORS COUPLED TOGI-PROTEINS CAN EASILY BE APPLIED TO THE FUNCTIONAL ASSAY OF OTHER CLONED NEUROTRANSMITTER RECEPTOR GENES.
Technology keywords
Not reported